Telephone +44 (0)845 299 3935

Fax +44 (0)1204 441 363

Enquiries enquiries@zerenex-molecular.com

Sales sales@zerenex-molecular.com

Get in touch

Top of page

Industry News

The divestment is expected to complete in the first quarter of 2020, subject to customary closing conditions and regulatory clearances.
Read More >

More Stories

News

Recent launch of several new categories of compound which include the spirocyclic β-Lactams designed...
Read More >

More Stories

Latest Tweets

Follow Us